US Metro Bancorp Announces Second Quarter 2025 Results
The Bank recorded on a year-to-date basis net interest income of $21.1 million compared to $16.9 million in the same period a year earlier. Net income of $5.8 million for the six months ending June 30, 2025, compared to $4.3 million reported for the same six months in 2024, a year over year increase of $1.6 million.
The Bank reported total assets of $1.452 billion as of June 30, 2025, representing a 7.7% increase compared to the reporting period ending June 30, 2024, and year over year loan growth of $102 million or 9.0%. Total Bank deposits ended the second quarter of 2025 at $1.281 billion, a $98 million or 8.3% increase from $1.183 billion on June 30, 2024.
Non-performing assets as a percentage of total assets was 1.11% on June 30, 2025, compared to 0.28% as of June 30, 2024. The Bank had no Other Real Estate Owned (OREO) on June 30, 2025. Allowance for credit losses (ACL) to gross loans was 1.20% as of June 30, 2025, compared to 1.20% as of June 30, 2024. The Bank recorded a $0.9 million provision for loan loss expense, for the six months ending June 30, 2025, compared to a $0.6 million provision recorded for the six months ending June 30, 2024.
'We are pleased with the positive performance in the second quarter of 2025 and year-over-year improvements to net income and notably to the net interest margin while the Bank continued to grow in both loans and deposits. The positive performance is expected to continue in the second half of the year.' said CEO Dong Il Kim.
US Metro Bank is a California chartered, full service commercial bank headquartered in Garden Grove, California. The Bank opened for business on September 15, 2006, and offers deposit and loan products (including commercial real estate, commercial and industrial, mortgage, SBA and USDA loans), as well as related banking services to its customers.
This release contains forward-looking statements, including our expectations with respect to future events that are subject to various risks and uncertainties. Factors that could cause actual results to differ materially from management's projections, forecasts, estimates and expectations include: fluctuation in market rates of interest and loan and deposit pricing, adverse changes in the overall national economy as well as adverse economic conditions in our specific market areas, maintenance and development of well-established and valued client relationships and referral source relationships, and acquisition or loss of key production personnel. Other risks that can affect the Bank are detailed from time to time in our annual reports. We caution readers that the list of factors above is not exclusive. The forward-looking statements are made as of the date of this release, and we may not undertake steps to update the forward-looking statements to reflect the impact of any circumstances or events that arise after the date the forward-looking statements are made. In addition, our past results of operations are not necessarily indicative of future performance.
US METRO BANCORP
CONSOLIDATED FINANCIAL HIGHLIGHTS (unaudited)
(All amounts in thousands except per share information)
At or for the Three Months Ended
6/30/2025 3/31/2025 % Change 6/30/2024 % Change
Net Income
$
2,453
$
2,587
-5.16%
$
2,185
12.25%
Net Income Per Share (Basic)
$
0.15
$
0.16
-5.16%
$
0.13
12.25%
ROAA (Annualized)
0.68%
0.73%
-0.05%
0.66%
0.02%
ROAE (Annualized)
9.34%
10.10%
-0.77%
9.00%
0.34%
Efficiency Ratio
69.54%
68.83%
0.71%
69.30%
0.24%
Assets
$
1,453,986
$
1,418,623
2.49%
$
1,349,130
7.77%
Gross Loans
$
1,229,567
$
1,198,131
2.62%
$
1,127,690
9.03%
Deposits
$
1,278,896
$
1,220,062
4.82%
$
1,181,974
8.20%
Non-Interest Bearing Deposits
$
224,561
$
218,496
2.78%
$
188,077
19.40%
Common Equity
$
106,191
$
103,941
2.16%
$
98,163
8.18%
Ending Common Shares O/S
16,520,000
16,520,000
-
16,520,000
-
Book Value Per Common Shares
$
6.43
$
6.29
$
0.14
$
5.94
$
0.49
US METRO BANK (only)
FINANCIAL HIGHLIGHTS (unaudited)
BALANCE SHEET
(All amounts in thousands except per share information)
Assets 6/30/2025 6/30/2024 Y-O-Y Change
Cash and Due From Bank
$
12,663
$
14,071
$
(1,408
)
-10.0
%
Investments and Fed Funds Sold
$
190,392
$
184,678
5,714
3.1
%
Gross Loans
1,229,567
1,127,691
101,876
9.0
%
Allowance for Credit Losses
(14,763
)
(13,511
)
(1,252
)
9.3
%
Other Assets
34,522
35,123
(601
)
-1.7
%
Total Assets
$
1,452,381
$
1,348,052
$
104,329
7.7
%
Liabilities and Capital 6/30/2025 6/30/2024 Y-O-Y Change
Deposits
$
1,281,111
$
1,183,450
$
97,661
8.3
%
Borrowings
20,000
25,000
(5,000
)
-20.0
%
Other Liabilities
15,886
17,887
(2,001
)
-11.2
%
Equity
135,384
121,715
13,669
11.2
%
Total Liabilities and Capital
$
1,452,381
$
1,348,052
$
104,329
7.7
%
STATEMENT OF OPERATIONS Three Months Ended
Income Statement 6/30/2025 3/31/2025 Q-O-Q Change
Interest Income
$
21,695
$
20,277
$
1,418
7.0
%
Interest Expense
10,576
10,250
326
3.2
%
Net Interest Income
11,119
10,027
1,092
10.9
%
Provision for Credit Losses
600
300
300
100.0
%
Other Income
2,834
3,158
(324
)
-10.3
%
Operating Expenses
9,172
8,743
429
4.9
%
Tax
1,231
1,244
(13
)
-1.0
%
Net Income
$
2,950
$
2,898
$
52
1.8
%
STATEMENT OF OPERATIONS Six Months Ended
Income Statement 6/30/2025 6/30/2024 Y-O-Y Change
Interest Income
$
41,972
$
38,984
$
2,988
7.7
%
Interest Expense
20,826
22,102
(1,276
)
-5.8
%
Net Interest Income
21,146
16,882
4,264
25.3
%
Provision for Credit Losses
900
600
300
50.0
%
Other Income
5,992
6,046
(54
)
-0.9
%
Operating Expenses
17,915
16,282
1,633
10.0
%
Tax
2,475
1,761
714
40.5
%
Net Income
$
5,848
$
4,285
$
1,563
36.5
%
Ratios 6/30/2025 6/30/2024 Y-O-Y Change
Net Loan to Deposits
94.82
%
94.15
%
0.68
%
ACL/Gross Loans
1.20
%
1.20
%
-
NPAs/Total Assets
1.11
%
0.28
%
0.83
%
Tier One Leverage Ratio
9.81
%
9.82
%
-0.01
%
YTD ROAA (annualized)
0.84
%
0.67
%
0.17
%
YTD ROAE (annualized)
9.05
%
7.13
%
1.92
%
Net Interest Margin (QTD)
3.17
%
2.77
%
0.40
%
Net Interest Margin (YTD)
3.09
%
2.70
%
0.39
%
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
12 minutes ago
- Toronto Star
Microbix Launches QUANTDx™ Characterized Reference Materials
MISSISSAUGA, Ontario, July 29, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QUANTDx™, a new product line of well-characterized reference materials designed to support the development and validation of diagnostic assays. QUANTDx is being launched at ADLM 2025, the conference of the Association for Diagnostic & Laboratory Medicine being held in Chicago, USA July 28-31, at which Microbix is exhibiting. The QUANTDx product line features accurately-quantified and fully-traceable reference materials that enable assay developers to establish key analytical performance metrics — such as LoD (limit of detection), Sensitivity (positive accuracy), and Specificity (negative accuracy) — that are essential for regulatory submissions and validation. The initial QUANTDx launch includes over 80 such reference materials that cover six of the most commonly tested disease panels, namely the following types of infections — fungal, human papillomaviruses, gastrointestinal, meningitis, respiratory, and sexually-transmitted. This comprehensive product line addresses a critical need within the infectious disease diagnostics industry for high-quality, reliable, and standardized reference materials.
Toronto Star
12 minutes ago
- Toronto Star
Abaxx to Pilot Digital Title Framework for Tokenized-USD Money Market Funds, Targeting Legal Finality and Identity Gaps in Real-Time Collateral
TORONTO, July 29, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) ('Abaxx' or the 'Company'), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, 'Abaxx Exchange' and 'Abaxx Clearing'), and producer of the SmarterMarkets™ Podcast, today announces the completion of a pre-feasibility study on the use of tokenized money market funds (MMFs) as financial collateral using Abaxx's proprietary ID++ and Private Digital Title technologies. Building on its Q4 2025 gold-backed collateral pilot, the Company is now advancing discussions with institutional partners to conduct a second pilot transaction in Q4 2025. This next phase will test how tokenized MMF shares — when paired with Abaxx's legal and identity infrastructure — can serve as legally enforceable, real-time collateral in regulated markets. The results will inform a full feasibility study and lay the foundation for the Abaxx USD Trust Network, as further detailed below.
Globe and Mail
12 minutes ago
- Globe and Mail
Almonty Appoints Respected U.S.-Based Financial Executive Brian Fox as Chief Financial Officer
Almonty Industries Inc. (' Almonty ' or the ' Company ') (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten critical to the U.S. defense and technology sectors, today announced the appointment of Brian Fox, CPA as Chief Financial Officer, succeeding Mark Gelmon, CPA,CA, effective August 25, 2025. Mr. Fox most recently served as Chief Financial & Operating Officer at CBIZ Marks Paneth, a top-tier U.S. accounting and advisory firm, where he played a key role in strategic growth initiatives and post-merger integration. His prior experience includes leadership roles at Loureiro Engineering and United Subcontractors, as well as senior audit work at Arthur Andersen. He holds a Master's degree in Management from Harvard University and a Bachelor of Science in Accounting from the University of Connecticut. Mr. Gelmon, who joined Almonty in 2015 through its acquisition of Woulfe Mining Corp. (former owner of the Sangdong Mine Project) and became CFO in 2017, will remain involved with the Company as a financial consultant. The Company thanks Mr. Gelmon for his unwavering dedication and years of service. Lewis Black, Chief Executive Officer of Almonty, commented: 'As Almonty advances its U.S. redomiciling strategy following our successful US$90 million public offering and Nasdaq listing, the appointment of a U.S.-based executive with deep financial and operational acumen was a deliberate and strategic move. Brian brings exactly the type of disciplined execution and institutional-grade financial leadership we need as we scale operations and align with U.S. capital markets. His track record in guiding complex organizations through growth and transformation will prove invaluable. We thank Mark for his years of dedication and are thrilled to welcome Brian to the team.' About Almonty Almonty (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1) is a leading supplier of conflict-free tungsten – a strategic metal critical to the defense and advanced technology sectors. As geopolitical tensions heighten, tungsten has become essential for armor, munitions, and electronics manufacturing. Almonty's flagship Sangdong Mine in South Korea, historically one of the world's largest and highest-grade tungsten deposits, is expected to supply over 80% of global non-China tungsten production upon reaching full capacity, directly addressing critical supply vulnerabilities highlighted by recent U.S. defense procurement bans and export restrictions by China. With established operations in Portugal and additional projects in Spain, Almonty is strategically aligned to meet rapidly rising demand from Western allies committed to supply-chain security and defense readiness. To learn more, please visit Legal Notice The release, publication, or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published, or distributed should inform themselves about and observe such restrictions. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward-Looking Information This news release contains 'forward-looking statements' and 'forward-looking information' within the meaning of applicable securities laws. All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as 'plan', 'development', 'growth', 'continued', 'intentions', 'expectations', 'emerging', 'evolving', 'strategy', 'opportunities', 'anticipated', 'trends', 'potential', 'outlook', 'ability', 'additional', 'on track', 'prospects', 'viability', 'estimated', 'reaches', 'enhancing', 'strengthen', 'target', 'believes', 'next steps' or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking statements in this news release include, but are not limited to, statements concerning the completion of the Offering, the Company's redomiciling initiatives, the Company's position as a leading supplier of tungsten to the U.S. and its allies, the timing of any listing of the Common Shares on the Nasdaq, the continued listing of the Common Shares on the TSX and the ASX and trading on the Frankfurt Stock Exchange, and the use of proceeds of the Offering. Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company's forward-looking information is based include, without limitation, the absence of market conditions that could adversely impact the Offering or the intended listing of the Common Shares on the Nasdaq; the satisfaction of all listing requirements of the Nasdaq and continued listing requirements of the TSX and ASX; the achievement of any closing conditions to the Offering; and the absence of material adverse changes in the Company's industry or the global economy including interest rates, inflationary pressures, supply chain disruptions, and commodity market volatility. Forward-looking statements are also subject to risks and uncertainties facing the Company's business, including, without limitation, the risks and uncertainties identified in the Registration Statement; risks relating to the Offering not being completed in a timely manner or at all, including due to unfavourable market or other conditions or factors; the possibility that the required approvals for or conditions to the Offering will not be received or satisfied on a timely basis or at all; changes in the anticipated timing for closing the Offering; business disruption during the pendency of or following the Offering; diversion of management time on Offering-related issues; the ability to retain members of Almonty's management team; the impact of the Offering on relationships with customers, suppliers, employees and other business counterparties; risks related to the reaction of customers, shareholders and members of the public to the Offering; and other events that could adversely impact the completion of the Offering, including industry or economic conditions outside of Almonty's control. Any of these risks could have a material adverse effect on the Company's business, financial condition, results of operations and growth prospects. Readers should consider reviewing the detailed risk discussion in the Company's Registration Statement, the most recent Annual Information Form and the amended Management Discussion and Analysis for the three months ended March 31, 2025 filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations. Although Almonty has attempted to identify important factors that could cause actual results, level of activity, performance or achievements to differ materially from those contained in forward-looking statements, there may be other factors that cause results, level of activity, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate and even if events or results described in the forward-looking statements are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, Almonty. Accordingly, readers should not place undue reliance on forward-looking statements and are cautioned that actual outcomes may vary. Investors are cautioned against attributing undue certainty to forward-looking statements. Almonty cautions that the foregoing list of material factors is not exhaustive. When relying on Almonty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Almonty has also assumed that material factors will not cause any forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
